NeuExcell Therapeutics is a preclinical biopharmaceutical company dedicated to the development and production of innovative drugs for the treatment of neurodegenerative diseases and nerve injuries,which are suitable for the treatment of many major brain diseases, including stroke, Alzheimer's disease, and Parkinson's disease. disease, Huntington's disease, traumatic brain injury, as well as retinal disease, spinal cord injury and ALS, among others.